Expert Pearls
A
| B
| C
| D
| E
| F
| G
| H
| I
| J
| K
| L
| M
| N
| O
| P
| Q
| R
| S
| T
| U
| V
| W
| X
| Y
| Z
| 0-9
|
Parkinson’s Disease - Glutathione Glutathione (reduced) 600 mg intravenously (I.V.) twice daily for 30 days resulted in 42% decline in disability. The improvement was seen after 3 weeks and particularly significant for rigidity and hypokinesia. Once GSH was stopped the therapeutic effect lasted for 2-4 months. [Prog Neuro-Psychopharmacol & Biol Psychiat 1996;20:1159-1170. 34377 (2000)] Summary Interview |
|
Parkinson’s Disease - Glutathione - 2 Glutathione parenterally, usually intravenously. [J Applied Nutr, 1999;51(1):3-15. 34948 (2000)] Summary Interview |
|
Parkinson’s Disease - Glutathione - 3 Glutathione - significant decrease in the level of reduced glutathione (GSH) in substantia nigra. [Prog Neuro-Psychopharmacol & Biol Psychiat 1996;20:1159-1170. 34377 (2000)] Summary Interview |
|
Parkinson’s Disease - Mitochondria Mitochondrial energy production deficit (acetyl-l-carnitine, CoQ10, phosphatidylserine, magnesium enhance mitochondrial ATP production). [J Applied Nutr, 1999;51(1):3-15. 34948 (2000)] Summary Interview |
|
Parkinson’s Disease - Pesticide Pesticide exposure. [J Applied Nutr, 1999;51(1):3-15. 34948 (2000)] Summary Interview |
|
Parkinson’s Disease - Transcranial Magnetic Stimulation Transcranial Magnetic Stimulation (rTMS) drugs + rTMS (1 Hz, 0.6 T, 100 stimuli per day for 7 days using a round coil). rTMS was repeated at least twice each year for 3 years. [Brain Research Bulletin, 2004;64:259-263. 42403 (01/2005)] Summary Interview |
| Powered by Sigsiu.NET |  |
